Browse Bills

93rd (26222)
94th (23756)
95th (21548)
96th (14332)
97th (20134)
98th (19990)

99th (15984)
100th (15557)
101st (15547)
102nd (16113)
103rd (13166)
104th (11290)

105th (11312)
106th (13919)
107th (16380)
108th (15530)
109th (19491)
110th (7009)

111th (19293)
112th (15911)
113th (9767)

S.959 — 93rd Congress (1973-1974) [93rd]

Sponsor:

Sen. Nelson, Gaylord [D-WI] (Introduced 02/21/1973)

Summary:

Summary: S.959 — 93rd Congress (1973-1974)

There is one summary for this bill. Bill summaries are authored by CRS.

Shown Here:
Introduced in Senate (02/21/1973)

Requires the submission of biological criteria and performance information by applicants for new drugs. Requires the inclusion of biological criteria relating to therapeutic effectiveness and safety.

Major Actions:

Summary: S.959 — 93rd Congress (1973-1974)

There is one summary for this bill. Bill summaries are authored by CRS.

Shown Here:
Introduced in Senate (02/21/1973)

Requires the submission of biological criteria and performance information by applicants for new drugs. Requires the inclusion of biological criteria relating to therapeutic effectiveness and safety.

Amendments:

Summary: S.959 — 93rd Congress (1973-1974)

There is one summary for this bill. Bill summaries are authored by CRS.

Shown Here:
Introduced in Senate (02/21/1973)

Requires the submission of biological criteria and performance information by applicants for new drugs. Requires the inclusion of biological criteria relating to therapeutic effectiveness and safety.

Cosponsors:

Summary: S.959 — 93rd Congress (1973-1974)

There is one summary for this bill. Bill summaries are authored by CRS.

Shown Here:
Introduced in Senate (02/21/1973)

Requires the submission of biological criteria and performance information by applicants for new drugs. Requires the inclusion of biological criteria relating to therapeutic effectiveness and safety.